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Abstract
Introduction Early structured resuscitation of severe sepsis has
been suggested to improve short term mortality; however, no
previous study has examined the long-term effect of this therapy.
We sought to determine one year outcomes associated with
implementation of early goal directed therapy (EGDT) in the
emergency department (ED) care of sepsis.
Methods We performed a longitudinal analysis of a prospective
before and after study conducted at a large urban ED. Adult
patients were enrolled if they had suspected infection, 2 or more
systemic inflammatory response criteria, and either systolic
blood pressure (SBP) <90 mmHg after a fluid bolus or lactate
>4 mM. Exclusion criteria were: age <18 years, no aggressive
care desired, or need for immediate surgery. Clinical and
outcomes data were prospectively collected on consecutive
eligible patients for 1 year before and 2 years after implementing
EGDT. Patients in the pre-implementation phase received non-
protocolized care at attending physician discretion. The primary
outcome was mortality at one year.
Results 285 subjects, 79 in the pre- and 206 in the post-
implementation phases, were enrolled. Compared to pre-
implementation, post-implementation subjects had a
significantly lower ED SBP (72 vs. 85 mm Hg, P < 0.001) and
higher sequential organ failure assessment score (7 vs. 5, P =
0.0004). The primary outcome of 1 year mortality was observed
in 39/79 (49%) pre-implementation subjects and 77/206 (37%)
post-implementation subjects (difference 12%; P = 0.04).
Conclusions Implementation of EGDT for the treatment of ED
patients with severe sepsis and septic shock was associated
with significantly lower mortality at one year.
Introduction
The rate of hospitalizations due to severe sepsis doubled dur-
ing the past decade with estimates indicating that approxi-
mately 750,000 persons are affected annually in the USA [1].
Age-adjusted population-based mortality from severe sepsis
appears to be increasing and sepsis currently ranks as the
10th leading cause of death in the USA [2]. Although much of
the therapy for severe sepsis occurs in intensive care units
(ICU), as many as 500,000 cases of severe sepsis are initially
managed in emergency departments (EDs) annually, with an
average ED length of stay of five hours [3]. These data under-
score the importance of ED diagnosis and therapeutic inter-
vention for severe sepsis.
Published meta-analytic data suggest a significant survival
benefit associated with the use of an early quantitative resus-
citation strategy targeting explicit resuscitation endpoints in
patients with sepsis [4]. The Surviving Sepsis Campaign inter-
national consensus guidelines for the management of severe
sepsis and septic shock make a grade B recommendation for
the routine use of early quantitative resuscitation [5]. The only
prospective randomized trial of quantitative resuscitation in the
ED was performed by Rivers and colleagues [6], which dem-
onstrated that early goal-directed therapy (EGDT) resulted in
a decrease in absolute in-hospital mortality of 16%. Since the
report by Rivers and colleagues, numerous investigators have
prospectively demonstrated that early identification and early
quantitative resuscitation of severe sepsis using EGDT in thePage 1 of 7
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vival in clinical (non-research) settings [7-10].
We are aware of no previously published data that measures
the long-term impact afforded by implementation of an early
quantitative resuscitation strategy for severe sepsis. In the
present study, we sought to test the hypothesis of a significant
mortality reduction at one year among patients treated with
EGDT in the ED compared with patients treated before proto-
col implementation.
Materials and methods
Study design and setting
We performed a longitudinal analysis of patients enrolled in a
prospective before and after study of the clinical effectiveness
of EGDT for the early treatment of severe sepsis and septic
shock in the ED [9]. All patients were enrolled in the ED at
Carolinas Medical Center, an urban 800-bed teaching hospi-
tal with more than 100,000 patient visits per year. The ED is
staffed by emergency medicine resident physicians super-
vised by board-certified emergency medicine attending physi-
cians. This study was approved and informed consent waived
by the institutional review board and privacy board of Caroli-
nas Healthcare System.
Treatment protocol
Our EGDT protocol and the clinical impact of its implementa-
tion has been previously reported in detail [9]. In brief, our pro-
tocol was the similar to that of Rivers and colleagues [6] in that
our early resuscitation targeted three physiologic endpoints:
central venous pressure (CVP), mean arterial pressure (MAP)
and central venous oxygen saturation (ScvO2) using various
stepwise therapeutic interventions to achieve predefined val-
ues of each endpoint. Our protocol differed from that
described by Rivers and colleagues in that: it was executed
only by ED physicians and nurses that were providing clinical
care to the patient; and it was initiated in the ED and care was
subsequently transitioned to the ICU during the resuscitation
period. The use of serum lactate concentrations to screen for
global hypoperfusion was encouraged but not mandated by
the protocol. Because this quantitative resuscitation protocol
was implemented relatively early after the original study (in
2005), no faculty or trainees at our hospital had prior experi-
ence with the use of a structured quantitative resuscitation
protocol for sepsis.
Study subjects
Eligible subjects were identified by board-certified emergency
physicians in the ED, and inclusion criteria were identical for
both phases: age 18 years and older; suspected or confirmed
infection; two or more systemic inflammatory response syn-
drome (SIRS) criteria [11] (heart rate >90 beats per minute,
respiratory rate >20 breaths per minute, temperature >38 or
<36°C, white blood cell count >12,000 or <4000 cells/mm3
or >10% bands); systolic blood pressure below 90 mmHg or
MAP below 65 mmHg after a 20 ml/kg isotonic fluid bolus OR
anticipated need for ICU care and a serum lactate concentra-
tion of 4.0 mM or higher. Exclusion criteria were: age less than
18 years; need for immediate surgery with an anticipated
departure to the operating room in less than six hours; abso-
lute contraindication for a chest central venous catheter. As
our intent was to measure the potential impact of the early
resuscitation program, subjects who did not survive the first six
hours of early resuscitation (e.g. care was withdrawn early or
the subject dies prior to the initial six hours of resuscitation)
were excluded post-hoc from both groups.
The pre-implementation phase encompassed 13 months, from
August 2004 to September 2005. During this time emergency
physicians identified candidates with the inclusion and exclu-
sion criteria and entered patient data in real-time on a compu-
ter in the ED using a secure web-based electronic collection
form [12]. In this phase, care was provided by emergency phy-
sicians at their discretion and no formal protocol was utilized.
The post-implementation phase encompassed two years, from
November 2005 to October 2007. During this phase identifi-
cation of an eligible patient triggered an alphanumeric page to
ancillary staff (ED and ICU charge nurses, respiratory thera-
pist, pharmacy, bed management) and both the protocol qual-
ity assurance nurse and physician. In all cases, the ED
physicians and staff identified the patients, initiated the resus-
citation protocol, placed the central venous catheter, and fol-
lowed the protocol until a bed in the ICU was available for
patient transfer. At the time of patient transfer from the ED to
ICU, clinical care was transferred from the ED physicians to
the admitting physicians.
Data analysis and outcomes
The primary outcome was one-year mortality rate. The admis-
sion date of the index visit for sepsis was used as the baseline
date and our query was intended to confirm deaths within one
year after the baseline date. We assessed for the primary out-
come through a two-tiered method. The first tier was to search
our healthcare system's electronic medical record database,
which contains all patient encounters within a healthcare sys-
tem of 23 acute care hospitals and 57 outpatient care facilities
in North and South Carolina, USA, using methods we have
previously described [13]. Using this process the primary out-
come was confirmed if: the subject had a documented visit to
a healthcare facility more than one year after the baseline date;
or the subject had a death confirmed via both an 'expired' dis-
charge status and a physician documented death note in a
healthcare facility within one year of the baseline date. For sub-
jects without a primary outcome using the electronic medical
records, we then progressed to a social security death index
(SSDI) search. We searched the master SSDI using every
combination of first, middle and last name, and social security
number [14]. Both of the above searches (medical record and
SSDI) were completed at 15 months or more after enrollment.Page 2 of 7
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alive or dead, we assumed the subject to be alive.
Additional data collected included demographics and clinical
variables, hospital resources utilized including the number of
both ICU and hospital days. For both hospital and ICU days, if
a patient spent any amount of time during the 24-hour period
of one day in the ICU or hospital, it was counted as a full day.
We also followed any sepsis-specific therapies that were
administered, such as parenteral corticosteroids and activated
protein C. The sequential organ failure assessment (SOFA)
score was calculated in all patients at the time of identification
[15].
Continuous data are presented as means ± standard devia-
tion, and when appropriate were compared for statistical dif-
ferences using unpaired t-tests or Mann Whitney U tests.
Categorical data are reported as proportions rounded to the
nearest whole number and associated 95% confidence inter-
vals (CI) and where applicable tested for significance using
Chi squared or Fisher's exact tests. The Kaplan-Meier survival
estimates and log-rank test for comparison were used for time-
to-death analysis. Cox proportional hazards regression was
performed in order to determine hazard ratios for death at one
year. The overall intent of the hazards regression was to deter-
mine the hazard ratios for death of patients who were treated
with EGDT while controlling for other important variables that
were found to have significant differences between our groups
in the bivariate analysis. For all statistical tests P < 0.05 were
considered significant.
Results
We enrolled 293 patients in the current study. Six subjects in
the post-implementation phase and two patients in the pre-
implementation phase were excluded post hoc for not receiv-
ing the full six hours of early resuscitation (all died in <6 hours).
Thus, we analyzed 79 subjects in the pre-implementation
phase and 206 in the post-implementation phase. Table 1
shows the demographics, co-morbidities, clinical variables,
severity of illness score, and source of suspected infections
between the groups. The groups were well matched for demo-
graphics and co-morbidities. Subjects in the post-implementa-
tion phase had variables suggesting a higher severity of illness
with a lower initial systolic blood pressure, higher initial respi-
ratory rate and higher initial SOFA score, as compared with
pre-implementation subjects.
Table 2 shows the resuscitative interventions utilized in the ini-
tial six hours of EGDT between the groups. Patients in the
post-implementation group were intubated more frequently,
received a significantly larger crystalloid volume and more fre-
quent infusion of vasopressors, as compared with the pre-
implementation group. We observed no significant differences
in the rate of packed red blood cell transfusion, dobutamine
administration, or median time to antibiotic administration. We
also observed an increase in both the mean ICU and hospital
length of stay in the post-implementation group.
The primary outcome of one-year mortality was observed in 39
of 79 (49%) patients in the pre-implementation phase and 77
of 206 (37%) patients in the post-implementation phase. Valid
outcome was unable to be reliably established in two patients
in the pre-implementation and four patients in the post-imple-
mentation phases. All of these patients were coded as 'alive'
for the analysis. The Kaplan-Meier survival estimate (Figure 1)
showed significant differences between the groups for the pri-
mary outcome of one-year morality (log rank test P = 0.04).
There was an increase in mortality during the year after treat-
ment with EGDT in both the pre-implementation and post-
implementation groups (Figure 2). The largest mortality
increase was seen at the time point of three months after hos-
pitalization in both groups. At one year after treatment,
between 40% (post-implementation phase) and 50% (pre-
implementation phase) of the subjects had expired.
Table 3 shows the results of the Cox proportional hazards
regression analysis. Subjects who received EGDT were found
to have a statistically significant reduction in risk of death at
one year (Hazard ratio 0.55, 95% CI 0.35 to 0.87). Initial
SOFA score was a predictor of one year mortality; however,
other factors such as dialysis dependent end-stage renal dis-
ease and corticosteroid treatment were not predictors of one-
year mortality.
Discussion
In this study we document the one year outcomes of subjects
treated with an EGDT algorithm for the management of severe
sepsis and septic shock in the ED. At one year, we found a sta-
tistically significant 12% mortality reduction among subjects
treated with the protocol suggesting a number needed to treat
(1/absolute mortality reduction) of approximately eight per-
sons to save one life for a year. This mortality reduction
remained significant in a multivariable model that controlled for
other potential explanatory variables. Furthermore, this mortal-
ity benefit was found among a group of patients with appar-
ently higher severity of illness based on lower systolic blood
pressures and higher sequential organ failure scores meas-
ured at enrollment.
We believe this report adds novel data to the early sepsis
resuscitation literature. In the original EGDT study published
by Rivers and colleagues, 60-day mortality was reported to be
57% in the standard therapy arm and 44% in the EGDT arm
[6]. In a prospective observational study, Karlsson and col-
leagues reported the in-hospital and one-year mortality of
severe sepsis in Finland [16]. Their findings are similar to our
pre-implementation group with the same in-hospital mortality
(28%) and a slightly lower one-year mortality of 41%. In the
report by Karlsson and colleagues, all subjects with SIRS cri-
teria and at least one with organ dysfunction were included.Page 3 of 7
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Table 1
Patient demographics, clinical characteristics, and physiological measurements
Pre-implementation Post-implementation
Variable n = 79 n = 206 P value
Age (mean years ± SD) 58 ± 16 56 ± 18 0.58
Race n, (%)
Caucasian 40 (51) 110 (54) 0.68
Black American 38 (48) 84 (41) 0.27
Gender n, (%)
Male 47 (59) 101 (49) 0.12
Female 32 (41) 105 (51) 0.12
Co-morbidities n, (%)
Diabetes mellitus 23 (29) 53 (26) 0.56
COPD 12 (15) 41 (20) 0.37
HIV 8 (10) 24 (12) 0.74
DD-End-stage renal disease 25 (32) 28 (14) 0.0008
Cancer 9 (11) 33 (16) 0.33
Organ transplant 3 (4) 4 (2) 0.4
Indwelling vascular line 7 (9) 27 (13) 0.33
Nursing home resident 18 (23) 39 (19) 0.47
Do not resuscitate 5 (6) 5 (2) 0.14
ED vital signs (mean ± SD)
Lowest SBP (median, (IQR) mmHg) 85 (73-91) 72 (65-79) < 0.0001
Highest pulse (beats/min) 118 ± 27 120 ± 25 0.5
Highest RR (breaths/min) 26 ± 9 30 ± 11 0.008
Highest temperature (°F) 101 ± 3 100 ± 3 0.04
Lowest O2 saturation (%) 94 ± 7 92 ± 7 0.35
Lowest CVP (mmHg) - 7 ± 4 -
Highest CVP (mmHg) - 13 ± 6 -
Lowest ScVO2 (%) - 67 ± 13 -
Highest ScVO2 (%) - 80 ± 11 -
ED SOFA score (mean ± SD) 5 ± 3 7 ± 4 0.0004
Lactate level** (mM, mean ± SD) 5 ± 3 4 ± 3 0.03
Suspected source of infection* n, (%)
Pulmonary 25 (32) 89 (43) 0.08
Urinary tract 21 (27) 58 (28) 0.8
Intra-abdominal 14 (1) 41 (20) 0.52
Skin/soft tissue 13 (20) 27 (13) 0.22
Blood (bacteremia) 2 (3) 21 (10) 0.03
Unknown 12 (15) 16 (8) 0.07
*Some patients had more than one suspected source, thus the total is more than 100%.
**Lactate was only available in 33 of 79 before group patients and 193 of 206 after group.
COPD = chronic obstructive pulmonary disease; CVP = central venous pressure; DD = dialysis dependent; ED = emergency department; HIV = 
human immunodeficiency virus; IQR = interquartile range; O2 = oxygen; RR = respiratory rate; SBP = systolic blood pressure; ScvO2 = central 
venous oxygen saturation; SD = standard deviation; SOFA = sequential organ failure assessment.
Available online http://ccforum.com/content/13/5/R167Our study required SIRS criteria and evidence of hypoper-
fusion (elevated lactate and/or hypotension after fluid chal-
lenge), which may account for the slight differences in
outcomes noted. Also, the study by Karlsson and colleagues
was observational and did not test implementation of a new
treatment paradigm as did the present study. The authors do
not mention EGDT and the incidence of its use in their study
is not reported. Thus we believe the present report to be the
first to document the long-term impact of an ED-based EGDT
protocol on survival.
Our data indicate that subjects who are treated for severe sep-
sis and septic shock have a stepwise increase in mortality over
the first year. This mortality increase over the first year was
found in both phases of our study. It might be questioned why
an early resuscitation would be associated with long-term mor-
tality. One interpretation of this finding, as indicated in Figure
2, is that among those subjects in the post-implementation
phase who derived the most benefit from the intervention were
individuals who were the most 'salvageable' (i.e., those individ-
uals who subsequently went on to survive to more than one
year). Another possibility for our findings could be related to a
Hawthorne effect, caused by heightened awareness of the
Table 2
Resuscitation interventions utilized in the initial six hours
Intervention Before group
n = 79
After group
n = 206
P value*
Endotracheal intubation n, (%) 7 (9) 55 (27) 0.0006
Crystalloid volume (median, (IQR) liters) 2.0 (1.0-3.4) 5.0 (3.8-7.2) < 0.0001
Vasopressor administration n, (%) 27 (34) 149 (72) < 0.0001
Dobutamine administration n, (%) 1 (1) 9 (4) 0.22
PRBC transfusion n, (%) 1 (1) 13 (6) 0.07
Other
Time to initial antibiotics (median, (IQR) minutes) 85 (50-190) 90 (55-156) 0.62
Steroid administration n, (%) 5 (6) 88 (43) < 0.0001
Activated protein C n, (%) 3 (4) 5 (2) 0.54
ICU length of stay, days 2 ± 3 4 ± 5 < .0001
Total hospital days, days 8 ± 6 10 ± 9 .0670
ICU = intensive care unit; IQR = interquartile range; PRBC = packed red blood cell.
Figure 1
Kaplan Meier survival curve comparing survival of patients in the pre-im lementation and post-imple entation phases
implementation and post-implementation phases. The P value shown 
was derived from the log-rank test.
Figure 2
Mortality rates over the course of the first year after the index emer-gency department visit for severe sepsi  or septic shock
gency department visit for severe sepsis or septic shock.Page 5 of 7
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mentation subject's clinical needs.
Our data also allow an inference into the expected one-year
mortality among patients undergoing aggressive therapeutic
intervention for sepsis using consensus recommendations [5],
which is important for the purpose of designing future clinical
trials incorporating longer range outcome assessment. Specif-
ically, 40% of aggressively treated subjects are dead at one
year after the index visit, suggesting a potential opportunity for
targeted improvement, particularly for investigators designing
trials that target longer term outcomes.
We found some important differences between the subjects in
the pre- and post-implementation groups. There were signifi-
cantly more subjects with dialysis dependent end-stage renal
disease in the pre-intervention group (32% vs. 14%). Patients
with end-stage renal disease who develop sepsis have been
shown to have a higher mortality compared with the general
population [17]. Also, significantly more subjects in the post-
intervention group were treated with corticosteroids, a therapy
which meta-analytic data have been suggested to have a ben-
eficial effect on short-term mortality [18]. Both of these group
differences could have an impact on the mortality benefit we
observed. To address this concern we performed proportional
hazards regression analyses, which revealed neither of these
variables to be independent predictors of one-year mortality in
our subjects.
The EGDT sepsis protocol comprises a resource intensive
therapeutic intervention. Our data show a two-day increase in
both ICU (statistically significant) and hospital length of stay
(not-statistically significant). Our findings are in contrast to
those of Rivers and colleagues who reported a non-significant
0.2 day difference in hospital length of stay between the con-
trol and EGDT group and did not report mean ICU length of
stay. This increase in resources utilized in the ICU is a finding
that deserves more investigation.
This report has several limitations that warrant discussion.
First, this is a single-center study that was not conducted as a
tightly controlled experimental investigation. As such, our
results may not be generalizable to other populations. Second,
therapies administered in the ED other than EGDT (e.g. antibi-
otics or steroids) or therapies administered after the EGDT
period (e.g. during the first 72 hours of ICU care) may have
contributed to the treatment effect we observed. Third, we
used a two-tiered approach to establish one-year mortality in
lieu of direct patient contact. Although we have previously
published the validity of these methods [13,19] it is possible
that our results might be different if a different follow-up
method were used. Fourth, because our cohorts are not con-
temporaneous but actually divided along a time continuum, it
is important to note that some of the study impact may be due
to changes in technology, skill or other factors during the study
period. Fifth, we did not measure physiological or severity of ill-
ness variables before and after the resuscitation in the post-
implementation group. Thus it remains possible that some of
the benefit demonstrated by the resuscitation was due to
heightened awareness of the patient's illness. Finally, we did
not quantify, explore, or exclude protocol deviations, because
this study was designed to determine the impact of EGDT
when implemented into a real-world clinical setting.
Conclusions
Implementation of EGDT in the ED for the early treatment of
severe sepsis and septic shock was associated with a signifi-
cantly lower mortality at one year. This is the first large pro-
spective study to suggest a long-term survival benefit
associated with early and aggressive resuscitative care for
sepsis.
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